GENETICS 101. An overview of human genetics and practical applications from an adult medical genetics clinic

Similar documents
section 2 What Is Neurofibromatosis Type 1?

Inheritable Connective Tissue Diseases: Or It s Probably Not Marfan s. RJ Willes 4/23/2018

FABRY DISEASE 12/30/2012. Ataxia-Telangiectasia. Ophthalmologic Signs of Genetic Neurological Disease

A growth disturbance and not a disorder with ligamentous laxity

Congenital Aortopathies Marfans, Loeys-Dietz, ACTA 2, etc. DATE: October 9 th, 2017 PRESENTED BY: Cristina Fuss, MD

Effect of Angiotensine II Receptor Blocker vs. Beta Blocker on Aortic Root Growth in pediatric patients with Marfan Syndrome

CLINICAL INFORMATION SHEET NEUROFIBROMATOSIS (NF)

A Case Of Marfan Syndrome With Ascending And Arch Of Aorta Aneurysm Presenting With Type A- Dissection Of Aorta.

Imaging in neurofibromatosis type 1: An original research article with focus on spinal lesions

CLINICAL INFORMATION SHEET

GENETIC TESTING FOR NEUROFIBROMATOSIS

VASCULITIS AND VASCULOPATHY

Random Pearls in Dysmorphology and Genetics

مارفان متلازمة = syndrome Marfan Friday, 15 October :19 - Last Updated Thursday, 11 November :07

Neurofibromatosis Type One: A Guide for Educators by Bruce R. Korf, M.D., Ph.D.

DNA Day Illinois 2013 Webinar: Newborn Screening and Family Health History. Tuesday, April 16, 2013

Appropriate Use Criteria for Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology (scores listed by Appropriate Use rating)

Marfan syndrome: diagnosis and management. JCS Dean Consultant and Honorary Reader, Department of Medical Genetics, Medical School, Aberdeen, Scotland

ROUTINE SURVEILLANCE FOR INDIVIDUALS WITH DOWN SYNDROME

Marfan s Disease in Pregnancy. A Review Of Five Recent Cases and a Consideration of Guidelines. Dr Len Kliman.

ctf.org MORE THAN NEWLY DIAGNOSED WITH NF1: A GUIDE TO THE BASICS

Case Report Marfan Syndrome: A Case Report

MARFANS SYNDROME-A CASE REPORT

Diseases of the aorta: Pediatric and adult clinical presentation of the main syndromes. Birgit Donner Universitäts-Kinderspital beider Basel

European CMR Certification: LIST OF PROCEDURES FORM

Corporate Medical Policy

Marfan syndrome affecting four generations of a family without ocular involvement

WHAT IS MARFAN SYNDROME?

Pre-participation Screening for the Prevention of sudden Cardiac Death in Young Athletes. Thomas W. Allen, DO, MPH

NF1 AND ME.. A GUIDE TO THE BASICS

Galafold (migalastat) or Fabrazyme (agalsidase beta) Prior Authorization Criteria:

Marfan syndrome: Report of two cases with review of literature

UK Genetic Testing Network Marfan syndrome testing guideline workshop

Cardiomyopathy in Fabry s disease

Living with Neurofibromatosis Type 1: A Guide for Adults

Problems in Pediatrics: Pediatric Cardiology Cases

(i) Family 1. The male proband (1.III-1) from European descent was referred at

Corporate Medical Policy

NIH Public Access Author Manuscript Nat Clin Pract Cardiovasc Med. Author manuscript; available in PMC 2008 October 3.

Cardiomyopathy Consequences. function of the myocardium for any reason. This is a serious disease in which the heart muscle

AMERICAN BOARD OF MEDICAL GENETICS AND GENOMICS

Information leaflet for patients and families. Marfan Syndrome

What s New in Newborn Screening?

Clinical Characteristics of Marfan Syndrome in Korea

Stage I: Rule-Out Dashboard

Marfan s Syndrome Meraj Ud Din Shah MD, DM, FICC

Gastrointestinal Stromal Tumor Causes, Risk Factors, and Prevention

AN INTRODUCTION TO BEHAVIOR GENETICS. Terence J. Bazzett. Sinauer Associates, Inc. Publishers Sunderland, Massachusetts 01375

Year 2003 Paper two: Questions supplied by Tricia

Genetics and Genetic Testing for Autism:

What s New in Newborn Screening?

Genetic Diseases. Genetic diseases occur when an individual s DNA has one or more abnormalities.

강직성척추염환자에서대동맥박리를동반한마르팡증후군 1 예

Dr Tracy Dudding Clinical Geneticist Hunter Genetics

Evolving phenotype of Marfan s syndrome

Aortopathy Gene Testing by Sanger sequencing

Molecular and Cellular Mechanisms

Neurofibromatosis. Information Leaflet

Information leaflet for patients and families. Huntington Disease (HD)

Idiopathic Bronchiectasis and Connective Tissue Fibrillinopathies: Dural Ectasia as a Marker of a Distinct Bronchiectasis Subgroup

Pompe Disease. Family Education Booklet. Division of Pediatric Genetics Metabolism and Genomic Medicine

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

How to Effectively Manage the Motor Symptoms of HD

Genetics and Inborn Errors of Metabolism

Fibrous Dysplasia in Children. Professor Nick Shaw Birmingham Children s Hospital, UK

Genetic Testing for Heritable Disorders of Connective Tissue

The Patient Perspective: diagnostic Exome Sequencing

Proximal 18q- Treatment and Surveillance ICD-10 = Q99.9 or Q93.89

Neurofibromatosis, type 1. Fawn Leigh, M.D.

Preferred language: PATIENT INFORMATION. Date of birth (dd/mm/yyyy): Age: Sex: Male Female. City: State: Country: Zip code:

THE CHILD WITH NEUROFIBROMATOSIS TYPE 1 (NF1) A GUIDE FOR

TITLE: Genetic and Epigenetic Differences in Monozygotic Twins with NF1

Formal Genetics of Humans: Modes of Inheritance. Dr. S Hosseini-Asl

Genetic Conditions and Services: An Introduction

Scoliotic curve patterns in patients with Marfan syndrome

Neurogenetics Mechanisms of Inheritance and Disease

Heterozygous Fabry Disease Females Are Not Just Carriers, But Suffer From

Interventions of interest are: Testing for genes associated with connective tissue diseases

HTAD PATIENT PATHWAY

Bicuspid Aortic Valve. Marfan Syndrome SUNDAY

Medications for Early/Mid Stage HD

Neurofibromatosis 2: Genetics and Prenatal Diagnosis

Neurofibromatosis type 1 and RASopathies

Medication Policy Manual. Topic: Fabrazyme, agalsidase beta Date of Origin: February 17, 2015

MP Genetic Testing for Marfan Syndrome, Thoracic Aortic Aneurysms and Dissections, and Related Disorders. Related Policies None

2

Neurofibromatosis (NF) Center

Neurofibromatosis Network Advocacy Program. NF Network Advocacy Program. Structure your Congressional meeting

Consequences of Cardiomyopathy. thickened and stiff, the left ventricle is most often affected. This results in a lack of pumping

What to Expect at Seattle Children s Hospital

Cardiovascular Disease

Case Report Neurofibromatosis Type 1 Complicated by Atypical Coarctation of the Thoracic Aorta

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death

Moving fast or moving slow: an overview of Movement Disorders

Pathophysiology. Tutorial 1 Genetic Diseases

Cardiovascular Diseases and Diabetes

Virtual Mentor American Medical Association Journal of Ethics September 2009, Volume 11, Number 9:

Common Genetic syndromes. Dr. E.M. Honey Department Genetics Division Human Genetics University of Pretoria

PREGNANCY AND CONGENITAL HEART DISEASE

Heart Disease. Signs and Symptoms

Transcription:

GENETICS 101 An overview of human genetics and practical applications from an adult medical genetics clinic

Historical timeline of genetics Discuss basics of genetics Discuss tools used in clinic Discuss some of the common referrals

Overview of genetics

TIMELINE OF GENETICS 1865: Heredity Transmitted in Units 1869: DNA first isolated 1902: Chromosome theory of inheritance 1909: The word gene is coined 1911: Chromosomes carry genes 1952: Genes are made of DNA 1953: DNA is a double helix 1955: Humans have 46 chromosomes 1956: Disease caused by DNA alteration 1959: Chromosome abnormalities identified

TIMELINE OF GENETICS 1961: First newborn screen for metabolic defect 1966: Genetic code cracked 1975: DNA first sequenced 1983: First disease gene mapped 1990: Human genome project launched 1995: Ban on genetic discrimination in work place 1997: Dolly the sheep is cloned 2003: Human genome fully sequenced 2003: Dolly the sheep is euthanized due to progressive lung disease 2011.

GENETICS: THE BASICS DNA Genes Chromosomes

WHAT HAPPENS WHEN THERE IS AN ERROR IN THE DNA CODE?

Clinical Applications

Cancer Pediatric Prenatal GENETICS Metabolic Adult

ADULT GENETICS Accept physician referred and self referred patients Reasons for referrals: Seek diagnosis of a familial condition Seek diagnosis to describe seemingly unrelated medical issues (stop the diagnostic odyssey ) Family planning Assist with medical management Want to be proactive about health

Adult Genetics Medical history Pregnancy history Developmental history Physical exam Review family medical history Photos (family and patient) Ultimately use these tools to determine diagnosis and/or appropriate tests!

Fabry Disease

FABRY DISEASE (ICD9: 272.7) Gene: GLA (alpha- galactosidase A) Locus: X chromosome Incidence: 1/50,000 males (Italian study 1/3100)

FABRY DISEASE Brain: cerebrovascular disease Nervous: acroparesthesia, hypohidrosis, pain crises Eyes: corneal whorling Heart: hypertrophic cardiomyopathy, arrhythmia, myocardial infarction, cardiovascular disease Gastrointestinal: cramping, bloating, diarrhea Kidney: proteinuria, progressive renal failure

Fabry Disease: Management Acroparesthesia Renal Disease Cerebrovascular Disease Cardiovascular Disease Enzyme replacement therapy Surveillance

Marfan syndrome

MARFAN SYNDROME (ICD9: 759.82) Gene: FBN1 (fibrillin) Locus: chromosome 15 Incidence: 1/5000; (no gender discrepancy)

MARFAN SYNDROME Eyes: ectopia lentis, myopia Heart: aortic root dilation, aortic root dissesction, mitral valve prolapse Lungs: spontaneou pneumothorax Skeletal: tall, lanky, arachnodactyly, joint hypermobility, pectus deformity, dural ectasia, scoliosis Skin: stretch marks

Marfan Syndrome: Management Eyes Eyeglasses Surgery Cardiac Monitor aorta Surgical intervention Medication Skeletal Surgical correction

Neurofibromatosis 1

NEUROFIBROMATOSIS 1 (ICD9: 237.71) Gene: NF1 (neurofibromin) Locus: chromosome 17 Incidence: 1/3000

Neurofibromatosis 1 Eyes: Lisch nodules, optic glioma Nervous: plexiform neurofibromas, cognitive disability Skeletal: pseduoarthrosis, scoliosis Skin: café-au-lait spots, cutaneous neurofibromas Other: hypertension

Neurofibromatosis 1: Management Surveillance Surgery

Huntington s Disease

Huntington Disease (ICD9: 333.4) Gene: HTT (huntingtin) Locus: chromosome 4 Incidence: 1/10,000

Huntington Disease: Key Features Cognition: Disinhibition, speech difficulties, slowed reaction time Physical: clumsiness, abnormal eye movements, dystonia, involuntary movements, poor balance, tripping/falling, chorea Psychologic: agitation, irritability, anxiety, disinhibition

Huntington Disease: Key Features Rigidity Bradykinesia Severe chorea Serious weight loss Inability to walk Inability to speak Swallowing problems, danger of choking Inability to care for oneself

Huntington Disease: Management Psychological assistance Medication Mitigate physical symptoms Psychiatric Supportive care Feeding tubes Nursing care End of life care

Clinical Genetics: Beyond the disease

Discrimination ADA GINA Affected versus at-risk Duty to warn/inform Implications for other family members Reproductive decision making

THANK YOU Cari Wells, MS CGC Certified Genetic Counselor Adult Medical Genetics Clinic University of Colorado Hospital T: 720-848-6589 Email: cara.wells@uch.edu